Consistency and adherence to the recommended dosage are essential for achieving the desired benefits
The 2023 revision was largely focused on formulation sameness and support for waiver of in vivo bioequivalence studies
Cruciani RA, Dvorkin E, Homel P, Culliney B, Malamud S, Shaiova L, et al
doi: 10.1046/j.1471-4159.1997.69020791.x 139 Mendez-DavidI.HenR.GardierA
Conversely, discontinuation rates were increased to 33.7% (95% CI 33.4, 34.0) at 1 year and 50.6% (95% CI 50.3, 50.9) at 3 years when using a grace period of 60 days (ESM Table 4)
Pick the Right Evaluation Choose the Focused Hormone Evaluation for TRT or BHRT, or the Medical Weight Loss Evaluation for GLP-1 therapy